Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol-Reference-Cited by-同舟云学术

Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol

Published:2011-01-17 Issue:5 Volume:152 Page:615-622
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Kuchinskaya Ekaterina,Heyman Mats,Nordgren Ann,Söderhäll Stefan,Forestier Erik,Wehner Peder,Vettenranta Kim,Jonsson Olafur,Wesenberg Finn,Sahlén Sigrid,Nordenskjöld Magnus,Blennow Elisabeth

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08532.x/fullpdf

Reference34 articles.

1. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy;Batova;Blood,1996

2. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia;Bertin;Genes Chromosomes Cancer,2003

3. Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92;Calero Moreno;Leukemia,2002

4. Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse;Carter;Blood,2001

5. Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia;Chim;Leukaemia & Lymphoma,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of a Zebrafish Knock-In Model Recapitulating Childhood ETV6::RUNX1-Positive B-Cell Precursor Acute Lymphoblastic Leukemia;Cancers;2023-12-13

2. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

3. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia;Hematological Oncology;2022-06-04

4. The Yin and Yang-Like Clinical Implications of the CDKN2A/ARF/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia;Genes;2021-01-09

5. CDKN2B downregulation and other genetic characteristics in T-acute lymphoblastic leukemia;Experimental & Molecular Medicine;2019-01